These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 27031484)
41. Whole brain imaging reveals distinct spatial patterns of amyloid beta deposition in three mouse models of Alzheimer's disease. Whitesell JD; Buckley AR; Knox JE; Kuan L; Graddis N; Pelos A; Mukora A; Wakeman W; Bohn P; Ho A; Hirokawa KE; Harris JA J Comp Neurol; 2019 Sep; 527(13):2122-2145. PubMed ID: 30311654 [TBL] [Abstract][Full Text] [Related]
42. Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques. Kim JH; Ha TL; Im GH; Yang J; Seo SW; Chung JJ; Chae SY; Lee IS; Lee JH Neuroreport; 2014 Mar; 25(4):211-8. PubMed ID: 24518227 [TBL] [Abstract][Full Text] [Related]
43. Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease. Dhenain M; Delatour B; Walczak C; Volk A Magn Reson Med; 2006 Mar; 55(3):687-93. PubMed ID: 16470593 [TBL] [Abstract][Full Text] [Related]
44. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Jack CR; Garwood M; Wengenack TM; Borowski B; Curran GL; Lin J; Adriany G; Gröhn OH; Grimm R; Poduslo JF Magn Reson Med; 2004 Dec; 52(6):1263-71. PubMed ID: 15562496 [TBL] [Abstract][Full Text] [Related]
45. SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain. Sillerud LO; Solberg NO; Chamberlain R; Orlando RA; Heidrich JE; Brown DC; Brady CI; Vander Jagt TA; Garwood M; Vander Jagt DL J Alzheimers Dis; 2013; 34(2):349-65. PubMed ID: 23229079 [TBL] [Abstract][Full Text] [Related]
46. Radiolabeled peptides for Alzheimer's diagnostic imaging: mini review. Barrios-Lopez B; Raki M; Bergström K Curr Radiopharm; 2013 Dec; 6(4):181-91. PubMed ID: 24283961 [TBL] [Abstract][Full Text] [Related]
47. Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. Ghaghada KB; Starosolski ZA; Bhayana S; Stupin I; Patel CV; Bhavane RC; Gao H; Bednov A; Yallampalli C; Belfort M; George V; Annapragada AV Placenta; 2017 Sep; 57():60-70. PubMed ID: 28864020 [TBL] [Abstract][Full Text] [Related]
49. Affinity of (nat/68)Ga-Labelled Curcumin and Curcuminoid Complexes for β-Amyloid Plaques: Towards the Development of New Metal-Curcumin Based Radiotracers. Rubagotti S; Croci S; Ferrari E; Iori M; Capponi PC; Lorenzini L; Calzà L; Versari A; Asti M Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608011 [TBL] [Abstract][Full Text] [Related]
50. Lerouge F; Ong E; Rositi H; Mpambani F; Berner LP; Bolbos R; Olivier C; Peyrin F; Apputukan VK; Monnereau C; Andraud C; Chaput F; Berthezène Y; Braun B; Jucker M; Åslund AK; Nyström S; Hammarström P; R Nilsson KP; Lindgren M; Wiart M; Chauveau F; Parola S Nanomedicine (Lond); 2022 Dec; 17(29):2173-2187. PubMed ID: 36927004 [TBL] [Abstract][Full Text] [Related]
52. [In vivo imaging of amyloid plaques in the brain]. Okamura N Nihon Ronen Igakkai Zasshi; 2004 Mar; 41(2):175-8. PubMed ID: 15148750 [TBL] [Abstract][Full Text] [Related]
53. Technetium-99m labeled pyridyl benzofuran derivatives as single photon emission computed tomography imaging probes for β-amyloid plaques in Alzheimer's brains. Cheng Y; Ono M; Kimura H; Ueda M; Saji H J Med Chem; 2012 Mar; 55(5):2279-86. PubMed ID: 22364445 [TBL] [Abstract][Full Text] [Related]
55. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Ansciaux E; Burtea C; Laurent S; Crombez D; Nonclercq D; Vander Elst L; Muller RN Contrast Media Mol Imaging; 2015; 10(3):211-24. PubMed ID: 25284012 [TBL] [Abstract][Full Text] [Related]
56. MR microscopy of human amyloid-β deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid. Nabuurs RJ; Natté R; de Ronde FM; Hegeman-Kleinn I; Dijkstra J; van Duinen SG; Webb AG; Rozemuller AJ; van Buchem MA; van der Weerd L J Alzheimers Dis; 2013; 34(4):1037-49. PubMed ID: 23340037 [TBL] [Abstract][Full Text] [Related]
57. 6-Methoxy-indanone derivatives as potential probes for β-amyloid plaques in Alzheimer's disease. Nan DD; Gan CS; Wang CW; Qiao JP; Wang XM; Zhou JN Eur J Med Chem; 2016 Nov; 124():117-128. PubMed ID: 27565554 [TBL] [Abstract][Full Text] [Related]
58. 19F and 1H MRI detection of amyloid beta plaques in vivo. Higuchi M; Iwata N; Matsuba Y; Sato K; Sasamoto K; Saido TC Nat Neurosci; 2005 Apr; 8(4):527-33. PubMed ID: 15768036 [TBL] [Abstract][Full Text] [Related]
59. Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison. Grandjean J; Derungs R; Kulic L; Welt T; Henkelman M; Nitsch RM; Rudin M Neuroimage; 2016 Jul; 134():1-11. PubMed ID: 27033685 [TBL] [Abstract][Full Text] [Related]